Inhibition of NOD-2 mediated NFkappaB activation in HEK293T cells assessed as inhibition of MDP-induced luciferase activity after 14 hrs by reporter gene assay
Agonist activity at human Nod2 expressed in HEK293-blue cells assessed as increase in NF-kappaB transcriptional activity at 20 uM incubated for 18 hrs using quanti blue assay based SEAP reporter gene assay
Agonist activity at human NOD2 stably expressed in HEK293 cells co-expressing secreted alkaline phosphatase assessed as NF-kappaB induction by liquid handler-assisted reporter gene assay
Antagonist activity at human NOD2 stably expressed in HEK293 cells co-expressing secreted alkaline phosphatase assessed as NF-kappaB induction by liquid handler-assisted reporter gene assay
Agonist activity at NOD2 receptor (unknown origin) expressed in HEK-Blue cells assessed as NF-kappaB transcriptional activity at 20 uM after 18 hrs by secreted embryonic alkaline phosphatase reporter gene assay relative to untreated control
Activation of NOD2 in human monocytes assessed as inhibition of MDP-stimulated TNF-alpha production preincubated for 30 mins prior to MDP stimulation measured after 6 hrs by immunoassay
Inhibition of MDP-induced human NOD2 signaling expressed in HEK-Blue cells preincubated for 3 hrs followed by MDP-stimulation for 20 hrs by spectrophotometry based SEAP reporter gene assay
Inhibition of NOD2 signaling in human PBMC derived macrophages assessed as inhibition of MDP-induced IL-6 mRNA expression at 1 to 10 uM preincubated for 1 hr followed by MDP-stimulation for 90 mins by RT-PCR method
Inhibition of MDP-stimulated human NOD2 activation expressed in HEK-Blue cells assessed as reduction in NOD2-mediated MAPK signaling by measuring decrease in phosphorylated p38 level preincubated for 1 hr followed by MDP-stimulation for 1 hr by Western blot method